No Data
No Data
Shenzhen Lifotronic Technology (SHSE:688389) Has A Rock Solid Balance Sheet
Lifotronic Technology to Build Industrial Base for 1 Billion Yuan; Shares Up 4%
Express News | Shenzhen Lifotronic Says It Plans to Invest 1 Bln Yuan in External Diagnostic Reagent Project
Shenzhen Lifotronic Technology Co., Ltd.'s (SHSE:688389) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
Shareholders of Shenzhen Lifotronic Technology Co., Ltd. (688389.SH) plan to reduce their shareholding by no more than 2.5% in total.
Pumeng Technology (688389.SH) announced that shareholder Xiamen Hanyu Investment Consulting Partnership Enterprise (Limited Partnership) (referred to as 'Xiamen Hanyu'), Xiamen Qiaochuan Investment Partnership Enterprise (Limited Partnership) (referred to as 'Xiamen Qiaochuan'), Xiamen Purong Investment Partnership Enterprise (Limited Partnership) (referred to as 'Xiamen Purong'), director and deputy general manager Li Dawei and supervisor Yang Jun plan to reduce their shareholding within three months after 15 trading days from the announcement of this plan, and within any consecutive 90 days, reduce no more than 4.2842 million shares in total through centralized bidding, which is no more than 1% of the total share capital of the company.
An Intrinsic Calculation For Shenzhen Lifotronic Technology Co., Ltd. (SHSE:688389) Suggests It's 27% Undervalued
No Data